Teladoc Health Stock Forecast, Price & News

Teladoc Health (NYSE:TDOC) Frequently Asked Questions

Is Teladoc Health a buy right now?

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last twelve months. There are currently 13 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Teladoc Health stock.
View analyst ratings for Teladoc Health or view top-rated stocks.

How has Teladoc Health's stock been impacted by Coronavirus (COVID-19)?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TDOC shares have decreased by 28.4% and is now trading at $98.41.
View which stocks have been most impacted by COVID-19.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Teladoc Health.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) issued its quarterly earnings data on Wednesday, October, 27th. The health services provider reported ($0.53) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.70) by $0.17. The health services provider had revenue of $521.70 million for the quarter, compared to analysts' expectations of $516.79 million. Teladoc Health had a negative net margin of 43.60% and a negative trailing twelve-month return on equity of 1.47%. The firm's revenue was up 80.6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.13) EPS.
View Teladoc Health's earnings history.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health issued an update on its FY 2021 earnings guidance on Thursday, December, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.02 billion-$2.03 billion, compared to the consensus revenue estimate of $2.02 billion.

What price target have analysts set for TDOC?

27 analysts have issued 1-year target prices for Teladoc Health's stock. Their forecasts range from $135.00 to $275.00. On average, they expect Teladoc Health's share price to reach $180.20 in the next year. This suggests a possible upside of 83.1% from the stock's current price.
View analysts' price targets for Teladoc Health or view top-rated stocks among Wall Street analysts.

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:

• Jason N. Gorevic, Chief Executive Officer & Director
• Mala Murthy, Chief Financial Officer (LinkedIn Profile)
• Jeff Nadler, Chief Information Officer
• Lewis Levy, Chief Medical Officer
• Claus Ingar Jensen, Chief Innovation Officer

What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health CEO Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among Teladoc Health's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Teladoc Health's key competitors?

Some companies that are related to Teladoc Health include Cano Health (CANO), 1Life Healthcare (ONEM), Hims & Hers Health (HIMS), Airsculpt Technologies (AIRS), DFP Healthcare Acquisitions (DFPH), Oncology Institute (TOI), LifeMD (LFMD), Concord Medical Services (CCM), Skylight Health Group (SLHG) and WellQuest Medical & Wellness (WEQL).
View all of TDOC's competitors.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), DocuSign (DOCU), salesforce.com (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (5.53%), Sumitomo Mitsui Trust Holdings Inc. (4.90%), Nikko Asset Management Americas Inc. (4.63%), Capital World Investors (3.57%), Citadel Advisors LLC (0.00%) and General Catalyst Group Management LLC (1.68%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David Travers, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Sandra L Fenwick, Stephany Verstraete, William H Frist and Yulun Wang.
View institutional ownership trends for Teladoc Health.

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Aviva PLC, General Catalyst Group Management LLC, Aequim Alternative Investments LP, American Century Companies Inc., Credit Suisse AG, PEAK6 Investments LLC, and California Public Employees Retirement System. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David Travers, David William Sides, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Mala Murthy, Sandra L Fenwick, Stephany Verstraete, and Yulun Wang.
View insider buying and selling activity for Teladoc Health or view top insider-selling stocks.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was acquired by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., Sumitomo Mitsui Trust Holdings Inc., Citadel Advisors LLC, SG Americas Securities LLC, Capital Fund Management S.A., Natixis, Baillie Gifford & Co., and Squarepoint Ops LLC.
View insider buying and selling activity for Teladoc Health or or view top insider-buying stocks.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $98.41.

How much money does Teladoc Health make?

Teladoc Health has a market capitalization of $15.75 billion and generates $1.09 billion in revenue each year. The health services provider earns $-485.14 million in net income (profit) each year or ($5.77) on an earnings per share basis.

How many employees does Teladoc Health have?

Teladoc Health employs 4,400 workers across the globe.

Does Teladoc Health have any subsidiaries?

The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..

When was Teladoc Health founded?

Teladoc Health was founded in 2002.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladochealth.com.

Where are Teladoc Health's headquarters?

Teladoc Health is headquartered at 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at (203) 635-2002 or via email at [email protected].